REFERENCES

1. National Cancer Center Cancer Information Service 2020. Available from: https://ganjoho.jp/en/public/statistics/short_pred.html. [Last accessed on 30 Sep 2021].

2. Kelly RJ. Emerging multimodality approaches to treat localized esophageal cancer. J Natl Compr Canc Netw 2019;17:1009-14.

3. Vellayappan BA, Soon YY, Ku GY, Leong CN, Lu JJ, Tey JC. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database Syst Rev 2017;8:CD010511.

4. Tanaka Y, Yoshida K, Sanada Y, Osada S, Yamaguchi K, Takahashi T. Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study. Cancer Chemother Pharmacol 2010;66:1159-65.

5. Tanaka Y, Yoshida K, Yamada A, et al. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma. Cancer Chemother Pharmacol 2016;77:1143-52.

6. Tanaka Y, Yoshida K, Osada S, Yamaguchi K, Takahashi T. Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study. Anticancer Res 2011;31:4589-97.

7. Tanaka Y, Yoshida K, Tanahashi T, Okumura N, Matsuhashi N, Yamaguchi K. Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma. Cancer Sci 2016;107:764-72.

8. Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today 2020;50:12-20.

9. Tanaka Y, Takahashi T, Yamaguchi K, Osada S, Shimokawa T, Yoshida K. Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study. Support Care Cancer 2016;24:933-41.

10. Tanaka Y, Ueno T, Yoshida N, et al. The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study). Esophagus 2018;15:239-48.

11. Tanaka Y, Ueno T, Yoshida N, et al. Is oral mucositis occurring during chemotherapy for esophageal cancer patients correctly judged? Anticancer Res 2019;39:4441-8.

12. Yoshida K, Tanaka Y, Imai T, et al. Subtotal stomach in esophageal reconstruction surgery achieves an anastomotic leakage rate of less than 1%. Ann Gastroenterol Surg 2020;4:422-32.

13. Kouw IW, Holwerda AM, Trommelen J, et al. Protein ingestion before sleep increases overnight muscle protein synthesis rates in healthy older men: a randomized controlled trial. J Nutr 2017;147:2252-61.

14. Brierley JD, Gospodarowicz MK, Wittekind C. . TNM classification of malignant tumours. 8th ed. Chichester: John Wiley & Sons, Ltd; 2017.

15. Blazeby J, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003;39:1384-94.

16. Ozawa S, Koyanagi K, Ninomiya Y, Yatabe K, Higuchi T. Postoperative complications of minimally invasive esophagectomy for esophageal cancer. Ann Gastroenterol Surg 2020;4:126-34.

17. Zhang W, Yu D, Peng J, Xu J, Wei Y. Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: a systematic review and meta-analysis. PLoS One 2017;12:e0173416.

18. Beecher SM, OʼLeary DP, McLaughlin R, Kerin MJ. The impact of surgical complications on cancer recurrence rates: a literature review. Oncol Res Treat 2018;41:478-82.

19. D'Journo XB, Ouattara M, Loundou A, et al. Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. Dis Esophagus 2012;25:527-34.

20. Schandl A, Kauppila JH, Anandavadivelan P, Johar A, Lagergren P. Predicting the risk of weight loss after esophageal cancer surgery. Ann Surg Oncol 2019;26:2385-91.

21. Oomura Y, Ono T, Ooyama H, Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature 1969;222:282-4.

22. Anderson GH, Woodend D. Consumption of sugars and the regulation of short-term satiety and food intake. Am J Clin Nutr 2003;78:843S-9S.

23. Yonei Y, Miwa Y, Hibino S, et al. Japanese anthropometric reference data - special emphasis on bioelectrical impedance analysis of muscle mass. Anti-Aging Med 2008;5:63-72.

24. Lobo DN, Gianotti L, Adiamah A, et al. Perioperative nutrition: recommendations from the ESPEN expert group. Clin Nutr 2020;39:3211-27.

25. Xueting H, Li L, Meng Y, et al. Home enteral nutrition and oral nutritional supplements in postoperative patients with upper gastrointestinal malignancy: a systematic review and meta-analysis. Clin Nutr 2021;40:3082-93.

26. Ida S, Hiki N, Cho H, et al. Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. Br J Surg 2017;104:377-83.

27. Aoyama T, Yoshikawa T, Ida S, et al. Effects of perioperative Eicosapentaenoic acid-enriched oral nutritional supplement on lean body mass after total gastrectomy for gastric cancer. J Cancer 2019;10:1070-6.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/